Precigen (PGEN) FCF Margin Growth (5y) (2017 - 2026)
Precigen (PGEN) FCF Margin Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,836.00 |
| Dec 31, 2025 | -20,569.00 |
| Sep 30, 2025 | -316,362.00 |
| Jun 30, 2025 | -233,770.00 |
| Mar 31, 2025 | -116,954.00 |
| Dec 31, 2024 | -2,999.00 |
| Sep 30, 2024 | -236.13 Mn |
| Jun 30, 2024 | -340,266.00 |
| Mar 31, 2024 | -148,910.00 |
| Dec 31, 2023 | -117,201.00 |
| Sep 30, 2023 | -172.43 Mn |
| Jun 30, 2023 | -81,428.00 |
| Dec 31, 2022 | 15,385.00 |
| Sep 30, 2022 | -18,175.00 |
| Jun 30, 2022 | -17,307.00 |
| Mar 31, 2022 | -28,726.00 |
| Dec 31, 2021 | 21,266.00 |
| Sep 30, 2021 | -54,698.00 |
| Jun 30, 2021 | -22,310.00 |
| Mar 31, 2021 | -4,600.00 |